Having posted a strong set of second-quarter results earlier this month, Shire Pharmaceuticals continues to develop a balance sheet that would impress any potential acquirer, according to analysts at Matrix Group.
The place of traffic for ENT & Bronchoscopy devices will continue to evolve globally, led ~ the agency of enhanced disease screening and detection techniques, rapidly aging population, ongoing emphasis on cost-effective and minimally invasive therapies, as well as technological advancements in diagnostics and therapeutics. Given the prevailing rise in ENT and lung disorders, the [...]
With the United States economy on such fragile footing, anything that undermines already low confidence levels could create a ripple effect and further stall the recovery.
LONDON (Reuters) - News and information company Thomson Reuters Corp.
Andrew Fieldhouse, Federal Budget Policy Analyst at the Economic Policy Institute, says a failure to reach a debt deal before August 2nd could push the economy back into recession with GDP falling by one percent.
June 30 - Michael Pento, Senior Economist at EuroPacific Capital, says expect a major move from stocks into commodities especially precious metals if no debt deal is done by Aug 2.
Jul (Reuters) - Western security agencies were most likely behind the killing of an Iranian scientist in an operation that underlines the myriad complications in the conflict over Iran's nuclear program, analysts say.
They say only the spread of the scandal to the U.S.
Rotterdam, July 2011 --- Analyst and investor optimism has dropped for virtually all industries over Q2 2011. Sovereign risk, higher oil prices, austerity and a corresponding decrease in expected consumer spending are underlying this drop. These findings are based on a global survey of over 200 analysts and investors.